Zobrazeno 1 - 10 of 68 pro vyhledávání: '"J. A. Diaz-Buxo"'
1
Is continuous ambulatory peritoneal dialysis adequate long-term therapy for end-stage renal disease? A critical assessment
Autor: J A Diaz-Buxo
Publikováno v: Journal of the American Society of Nephrology. 3:1039-1048
The significant growth in the continuous ambulatory peritoneal dialysis (CAPD) population and the recent interest in the quantitation of dialysis delivered have stimulated much work in the field of kinetic modeling, correlation between model paramete
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::90030a49f4c31b5a1144b2724853a10d
https://doi.org/10.1681/asn.v351039
Zobrazit plný text záznamu
2
Peritoneal dialysis solutions--at a crossroad
Autor: J A, Diaz-Buxo, L, Gotloib
Publikováno v: Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 58(2)
After many decades of evolution and with many choices available for the formulation of peritoneal dialysis fluids (PDF), we find ourselves at a crossroads. A review of related developments, laboratory trials and clinical evaluations is offered to sti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9df7c2c3d87779f05e9df5c5f7f9d4da
https://pubmed.ncbi.nlm.nih.gov/16767068
Zobrazit plný text záznamu
5
The treatment of anemia in peritoneal dialysis patients
Autor: E, Lacson, J A, Diaz-Buxo
Publikováno v: Clinical nephrology. 56(6)
The management of anemia in patients with end-stage renal disease (ESRD) treated with peritoneal dialysis (PD) has gained increasing attention over the past decade, similar to patients on hemodialysis (HD). However, there are many differences between
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fc9338c1e830932faad3a76a85f778cc
https://pubmed.ncbi.nlm.nih.gov/11770793
Zobrazit plný text záznamu
6
Modality selection
Autor: J A, Diaz-Buxo
Publikováno v: Journal of the American Society of Nephrology : JASN. 9
Dialysis modality selection should be based on patient preference and medical indications. Every effort should be made to provide adequate dosing of dialysis by using guidelines supported by clinical outcome evidence. All patients should receive expl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::75302a7c68152726e524b9aa0feef3f8
https://pubmed.ncbi.nlm.nih.gov/11443757
Zobrazit plný text záznamu
7
Empiric initial therapy and dose of vancomycin
Autor: J A, Diaz-Buxo, G R, Bailie
Publikováno v: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 20(6)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4515408602d410b8939582ef7652f4b6
https://pubmed.ncbi.nlm.nih.gov/11405184
Zobrazit plný text záznamu
8
Peritonitis and antibiotic therapy in patients on cycler peritoneal dialysis--an update
Autor: J A, Diaz-Buxo, T L, Crawford
Publikováno v: Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 16
The increased use of automated peritoneal dialysis (APD) and the inherent differences between continuous ambulatory peritoneal dialysis (CAPD) and APD have generated interest in the treatment of peritonitis in cycler patients. This review considers v
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d9e1c577f7b4d900296cacc8c3811abd
https://pubmed.ncbi.nlm.nih.gov/11045300
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje